Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao

Blood (2022) 140 (Supplement 1): 3739–3740.

https://doi.org/10.1182/blood-2022-164677

Published: 2022

Journal Articles

Th17 Cells Exhibit Anti-Tumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Zonghong Shao, MD, Jing Li, Lanzhu Yue, Huaquan Wang, MD, Chunyan Liu, Hui Liu, Tao Jinglian, Weiwei Qi, Yihao Wang, Wei Zhang, Rong Fu, PhD

Blood (2016) 128 (22): 5558.

https://doi.org/10.1182/blood.V128.22.5558.5558

Published: 2016

Journal Articles

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Rong Fu, MD, Zhaoyun Liu, Hui Liu, Jia Song, Guojin Wang, Yihao Wang, Lijuan Li, Zonghong Shao, MD

Blood (2015) 126 (23): 5311.

https://doi.org/10.1182/blood.V126.23.5311.5311

Published: 2015

Journal Articles

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

Rong Fu, MD, Xin Yuan, Chunyan Liu, Hui Liu, Yihao Wang, Tong Chen, Lijuan Li, Jia Song, Guojin Wang, Zonghong Shao, MD

Blood (2015) 126 (23): 4767.

https://doi.org/10.1182/blood.V126.23.4767.4767

Published: 2015

Journal Articles

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Yinping Meng, Yihao Wang, Hui Liu, Yi Liu, Lijuan Li, Shaoxue Ding, Erbao Ruan, MD, Huaquan Wang, MD, Guojin Wang, Jia Song, Zonghong Shao, MD

Blood (2015) 126 (23): 4532.

https://doi.org/10.1182/blood.V126.23.4532.4532

Published: 2015

NARROW

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Th17 Cells Exhibit Anti-Tumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Email alerts

ASH Publications

American Society of Hematology

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Th17 Cells Exhibit Anti-Tumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only